Skip to main content
SpringerLink
Log in

Coactivators and corepressors in endocrine diseases

  • Commentary
  • Published:
Endocrine Pathology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Horowitz KB, Jackson TA, Bain DL, Richer JK, Takimoto GS, Tung L. Nuclear receptor coactivators and corepressors. Mol Endocrinol 10:1167–1177, 1996.

    Article  Google Scholar 

  2. Glass CK, Rose DW, Rosenfeld MG. Nuclear receptor coactivators. Curr Opinion Cell Biol 9:222–232, 1997.

    Article  PubMed  CAS  Google Scholar 

  3. Wu C. Chromatin remodeling and the control of gene expression. J Biol Chem 272: 28,171–28,174, 1997.

    CAS  Google Scholar 

  4. Grunstein M. Histone acetylation in chromatin structure and transcription. Nature 389:349–352, 1997.

    Article  PubMed  CAS  Google Scholar 

  5. Ogryzko VV, Schiltz RL, Russanova V, Nakatani Y. The transcriptional coactivator p300 and CBP are histone acetyltransferases. Cell 87:953–960, 1996.

    Article  PubMed  CAS  Google Scholar 

  6. Spencer TE, Jenster G, Burcin MM, Allis CD, Zhou J, Mizzen CA, McKenna NJ, Onate SA, Tsai SY, Tsai M-J, O'Malley BW. Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389:194–198, 1997.

    Article  PubMed  CAS  Google Scholar 

  7. Yang X-Y, Ogryzko VV, Nishikawa J, Howard BH, Nakatani Y. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382:319–324, 1996.

    Article  PubMed  CAS  Google Scholar 

  8. Heinzel T, Lavinsky RM, Mullen T-M, Soderström M, Laherty CD, Torchia J, Yang W-M, Brard G, Ngo SD, Davie JR, Seto E, Eisenman RN, Rose DW, Glass CK, rosenfeld MG. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387:43–48, 1997.

    Article  PubMed  CAS  Google Scholar 

  9. Oñate SA, Tsai SY, TSai M-J, O'Malley BW. Sequence and characterization of a coactivator for the steroid hormone receptor superfamity. Science 270:1354–1357, 1995.

    Article  PubMed  Google Scholar 

  10. Li H, Gomes PJ, Chen JD. RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2. Proc Natl Acad Sci USA 94:8479–8484, 1997.

    Article  PubMed  CAS  Google Scholar 

  11. Voegel JJ, Heine MJS, Zechel C, Chambon P, Gronemeyer H. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J 15:3667–3675, 1996.

    PubMed  CAS  Google Scholar 

  12. Chen H, Lin RJ, Schiltz RL, Chakravarti D, Nash A, Nagy L, Privalsky ML, Nakatani Y, Evans RM. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with p/caf and CBP/p300. Cell 90:569–580, 1997.

    Article  PubMed  CAS  Google Scholar 

  13. Cavailles V, Dauvois S, L'llorser F, Lopez G, Hoarc S, Kushner PJ, Parker MG. Nuclear factor R1P140 modulates transcriptional activation by the estrogen receptor. EMBO J 14:3741–3751, 1995.

    PubMed  CAS  Google Scholar 

  14. Yeh S, Chang C. Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells. Proc Natl Acad Sci USA 93:5517–5521, 1996.

    Article  PubMed  CAS  Google Scholar 

  15. Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan X-Y, Sauter G, Kallioniemi O-P, Trent JM, Meltzer PS. AIBI, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277:965–968, 1997.

    Article  PubMed  CAS  Google Scholar 

  16. Takeshita A, Cardona GR, Koibuchi N, Suen C-S, Chin WW. TRAM-1, a novel 160-kDa thyroid hormone receptor activator molecule, exhibit distinct properties from steroid receptor coactivator-1. J Biol Chem 272:27,629–27,634, 1997.

    Article  CAS  Google Scholar 

  17. Hollenberg A, Monden T, Cohen R, Madura J. A nuclear hormone receptor coactivaring protein contains a selective receptor interacting domain which preferentially binds the thyroid hormone receptor. 70th Ann Meeting Am Thyroid Assoc, Colorado Springs, CO, 1997, pS-111 (Abstract).

  18. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin S-C, Heyman R, Rose D, Glass C, Rosenfels M. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:1–12, 1996.

    Article  Google Scholar 

  19. Hanstein B, Eckner R, DiRenzo J, Halachmi S, Liu H, Searcy B, Kurokawa R, Brown M. p300 is a component of an estrogen receptor coactivator complex. Proc Natl Acad Sci USA 93:11,540–11,545, 1996.

    Article  CAS  Google Scholar 

  20. Hörlein AJ, Näär AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Soderstrom M, Glass CK, Rosenfeld MG. Ligand-dependent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397–403, 1995.

    Article  PubMed  Google Scholar 

  21. Chen JD, Evans RM. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454–457, 1995.

    Article  PubMed  CAS  Google Scholar 

  22. Ayer DE, Lawrence QA, Eisenman RN. Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell 80:767–776, 1995.

    Article  PubMed  CAS  Google Scholar 

  23. Alland L, Muhle R, Hou Jr H, Potes J, Chin L, Schreiber-Agus N, DePihno RA. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 387:49–55, 1997.

    Article  PubMed  CAS  Google Scholar 

  24. Petrij F, Giles RH, Dauwerse HG, Saris JJ, Hennekam RCM, Masuno M, Tommerup N, Van Ommen G-J, Goodman RH, Peters DJM, Breuning MH. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 76:348–351, 1995.

    Article  Google Scholar 

  25. Borrow J, Stanton Jr VP, Andresen JM, Becher R, Behm FG, Chaganti RSK, Civin CI, Disteche C, Dube I, Frischauf AM, Horsman D, Mitelman F, Volinia S, Watmore AE, Housman DE. The translocation t(8;16) (p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nature Genetics 14:33–41, 1996.

    Article  PubMed  CAS  Google Scholar 

  26. Taki T, Sako M, Tsuchida M, Hayashi Y. The t(11;16) (q23;p13) translocation in myelodysplastic syndrome fuses the MLL gene to the CBP gene. Blood 89:3945–3950, 1997.

    PubMed  CAS  Google Scholar 

  27. Trouche D, Cook A, Kouzarides T. The CBP co-activator stimulates E2F1/DP1 activity. Nucleic Acid Res 24:4139–4145, 1996.

    Article  PubMed  CAS  Google Scholar 

  28. Avantaggiati ML, Ogryzko V, Gardner K, Giordano A, Levine AS, Kelly K. Recruitment of p300/CBP in p53-dependent signal pathways. Cell 89:1175–1184, 1997.

    Article  PubMed  CAS  Google Scholar 

  29. Gu W, Roeder RG. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90:595–606, 1997.

    Article  PubMed  CAS  Google Scholar 

  30. Muraoka M, Konishi M, Yanoshita R, Tanaka K, Shitara N, Chong JM, Iwama T, Miyaki M. p300 gene alterations in colorectal and gastric carcinomas. Oncogene 12:1565–1569, 1996.

    PubMed  CAS  Google Scholar 

  31. Laherty CD, Yang W-M, Sun J-M, Davie JR, Seto E, Eiseman RN. Histone deacetylase associated with the mSin3 corepressor mediate Mad transcriptional repression. Cell 89:349–356, 1997.

    Article  PubMed  CAS  Google Scholar 

  32. Yoh SM, Chatterjee VKK, Privalsky MI. Thyroid hormone resistance syndrome manifests as an aberrant interaction between mutant T3 receptors and transcriptional corepressors. Mol Endocrinol 11:470–480, 1997.

    Article  PubMed  CAS  Google Scholar 

  33. Yogonathan T, Yang Y-F, Hawryluk B, Mori S, Rousseau P, Butt TR, Walfish PG, Differences in T3-dependent GR1P1 coactivator interactions among human T3 receptor β resistance to thyroid hormone mutants. 70th Ann Meeting Am Thyroid Assoc, Colorado Springs, CO, 1997, pS-34 (Abstract).

  34. Jackson TA, Richer JK, Bain DL, Takimoto GS, Tung L, Horowitz KB. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator and the corepressors N-CoR and SMRT. Mol Endocrinol 11:693–705, 1997.

    Article  PubMed  CAS  Google Scholar 

  35. Smith CL, Nawaz Z, O'Malley BW. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. Mol Endocrinol 11:657–666, 1997.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Laboratory, Medicine and Pathology, Hilron 8, 200 First St. SW, 55905, Rochester, MN

    Elzbieta Kulig PhD

Authors
  1. Elzbieta Kulig PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elzbieta Kulig PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kulig, E. Coactivators and corepressors in endocrine diseases. Endocr Pathol 9, 1–7 (1998). https://doi.org/10.1007/BF02739946

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02739946

Keywords

Search

Navigation